New drug JADE101 tested in healthy people for safety
Knowledge-focused
Ongoing
This early-stage study tests a new drug called JADE101 in 32 healthy adults aged 18-55. The main goal is to check if it is safe and how the body handles it. Participants receive either a single dose of JADE101 or a placebo. This study does not aim to treat any disease.
Phase: PHASE1 • Sponsor: Jade Biosciences, Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:37 UTC